Senior Product Security Engineer
Goodleap- Full Time
- Senior (5 to 8 years), Mid-level (3 to 4 years)
Candidates should possess experience in application and product security, coupled with a strong understanding of relevant technology stacks, and expertise in building secure designs for software products or performing penetration testing for software products. They should also demonstrate an ability to understand code and system configurations and recommend modifications to ensure a better security posture, along with in-depth knowledge of software development and the ability to effectively build and communicate security designs considering the software design context. Furthermore, candidates must have an understanding of three or more security domains, such as platform security and network security.
The Sr Product Security Engineer will drive secure design in collaboration with development teams, deliver security requirements at the system and software levels, partner with development teams to implement security measures, guide and advise the Verification Team on cybersecurity verification, conduct Cybersecurity Risk Assessments on projects, and execute/facilitate various cybersecurity testing methods. They will also tirelessly work on integrating Product Security into the Software Development Lifecycle (SDLC), educate and train partner teams on security topics, and be responsible for introducing security controls, processes, and testing throughout the entire product SDLC, from hardware selection to decommissioning the device.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.